• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Barcelo Daniel was granted 333,333 shares, increasing direct ownership by 70% to 808,333 units (SEC Form 4)

    1/3/25 4:15:03 PM ET
    $FREY
    Industrial Machinery/Components
    Miscellaneous
    Get the next $FREY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Barcelo Daniel

    (Last) (First) (Middle)
    6&8 EAST COURT SQUARE
    SUITE 300

    (Street)
    NEWNAN GA 30263

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    FREYR Battery, Inc. /DE/ [ FREY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    01/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/01/2025 A 333,333(1) A $0(2) 808,333 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (RSUs) (2)(3) 01/01/2025 A 666,667 (4) (4) Shares of Common Stock 666,667 $0(2) 1,041,666 D
    Explanation of Responses:
    1. Consists of RSUs vested on the date of issuance.
    2. The RSUs will be net settled in shares of Common Stock.
    3. Each RSU represents a right to receive one share of Common Stock granted pursuant to the FREYR Battery, Inc. 2021 Equity Incentive Plan (as amended and restated).
    4. The RSUs will vest ratably on an accelerated basis from the January 1, 2025 grant date. One-third (1/3) of the units vested on January 1, 2025. One-third (1/3) of the units shall vest on January 1, 2026. One-third (1/3) of the units shall vest on January 1, 2027.
    Remarks:
    Exhibit List Exhibit 24.1 - Power of Attorney
    By: /s/ Daniel Barcelo 01/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FREY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FREY

    DatePrice TargetRatingAnalyst
    12/20/2024$4.00Neutral → Buy
    BTIG Research
    11/14/2023$13.00 → $2.00Overweight → Equal-Weight
    Morgan Stanley
    11/10/2023Buy → Neutral
    BTIG Research
    10/25/2023$14.00 → $7.00Outperform → Market Perform
    TD Cowen
    7/18/2023$14.00 → $10.00Buy → Neutral
    Goldman
    6/29/2023$13.00Equal-Weight → Overweight
    Morgan Stanley
    2/10/2023$13.00Buy
    BofA Securities
    1/25/2023$26.00 → $13.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings